NORTHWEST BIOTHERAPEUTICS INC Debt Instrument, Face Amount
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Debt Instrument, Face Amount of $65.55 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-08-14
- 2026-06-30: Debt Instrument, Face Amount $65.55M.
- 2026-03-31: Debt Instrument, Face Amount $66.91M.
- 2025-12-31: Debt Instrument, Face Amount $66.64M.
- 2025-09-30: Debt Instrument, Face Amount $61.80M.
| Period end | Debt Instrument, Face Amount | Debt Instrument, Face Amount as first filed |
|---|---|---|
| 2026-06-30 | $65.55M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $66.91M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $66.64M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $61.80M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $58.94M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $59.73M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $60.03M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $51.84M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $52.53M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $45.66M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $40.77M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $34.37M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $27.71M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $28.81M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $22.45M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $27.58M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $27.90M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $30.46M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $35.24M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $21.41M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $21.28M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $20.43M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $13.75M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $16.96M 10-Q · filed 2021-01-15 | |
| 2020-06-30 | $15.46M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $13.17M 10-Q · filed 2020-06-24 | |
| 2019-12-31 | $13.41M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $14.44M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $14.44M 10-Q · filed 2019-11-12 | $17.30M 10-Q · filed 2019-08-09 |
| 2019-04-30 | $5.40M 10-Q · filed 2019-11-12 | |
| 2019-03-31 | $18.98M 10-Q · filed 2019-05-10 | |
| 2019-03-29 | $4.40M 10-Q · filed 2019-05-10 | |
| 2019-02-28 | $4.40M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $17.43M 10-K · filed 2020-03-16 | |
| 2018-11-07 | $3.70M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $32.75M 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $32.50M 10-Q · filed 2018-08-14 | |
| 2018-04-30 | $5.40M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $31.02M 10-Q · filed 2018-05-16 | |
| 2018-02-28 | $1.40M 10-Q · filed 2019-08-09 | |
| 2017-12-31 | $31.38M 10-K · filed 2019-04-02 | |
| 2017-09-30 | $27.82M 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $32.66M 10-Q · filed 2017-08-21 | |
| 2017-03-31 | $34.20M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $32.56M 10-K · filed 2018-04-17 | |
| 2016-09-30 | $21.57M 10-Q · filed 2016-11-10 | |
| 2015-12-31 | $23.73M 10-K · filed 2017-04-17 | |
| 2015-02-15 | $1.00K 10-Q · filed 2015-05-11 | |
| 2011-09-30 | $5.40M 10-Q · filed 2012-11-14 |